Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab), IgG1, Monoclonal

Produktübersicht

• Artikelname: Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab), IgG1, Monoclonal
• Artikelnummer: SYB-CHA422
• Hersteller Artikelnummer: CHA422
• Alternativnummer: SYB-CHA422-100UG,SYB-CHA422-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics
• Spezies Reaktivität: Human

Produktbeschreibung

Anti-SLC34A2 Reference Antibody (Lifastuzumab)(CHA422) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 146.6 kDa.

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1mg/ml
• Isotyp: IgG1
• UniProt: O95436
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >95%
• Formulierung: Lyophilize
• Target-Kategorie: NaPi2b / SLC34A2